Abstract:Abstract Probiotics are defined as live microorganisms that confer a health benefit on the host when administered in adequate amounts. Bacillus coagulans GBI-30, 6086 (BC30) is a commercially available, lactic acid-producing, spore-forming bacteria that exhibits diverse functions. Contrary to most lactic acid-producing bacteria, B. coagulans spores can withstand extreme conditions, lending resiliency through commercial pet food processing, storage, and chemical and enzymatic digestion through the gastrointestinal tract. Previous studies in humans and livestock suggest B. coagulans have probiotic potential, although research in dogs is limited. Therefore, the objectives were to determine the effects of B. coagulans on nutrient digestibility, hematology, immunoglobulin concentrations, and fecal characteristics, metabolites, and microbiota populations of healthy adult dogs before and after an abrupt diet change. Pointer dogs [n = 12; age = 5.9 ± 2.5 yr; body weight (BW) = 26.6 ± 6.1 kg] were used in a replicated 3 × 3 Latin square design and fed commercial diets containing no probiotics or prebiotics. Probiotic or placebo capsules were administered before each daily feeding, with the following treatments tested: 1) basal diet + placebo (control; 250 mg maltodextrin); 2) basal diet + B. coagulans (low dose; 5 x 108 CFU/d); and 3) basal diet + B. coagulans (high dose; 2.5 x 109 CFU/d). An extruded kibble diet was fed to all dogs during a 28-d diet transition phase, after which dogs were abruptly switched to a commercial canned diet with fecal samples collected 2-, 6-, 10-, and 14-d after diet change. All data were analyzed using the Mixed Models procedure of SAS 9.4, with P < 0.05 being significant. Prior to dietary change, nutrient digestibility, food intake, immunoglobulin concentrations, metabolites, and hematology were not affected by treatment. However, fecal scores were decreased (P < 0.05; firmer stools) in dogs fed B. coagulans than controls. Also, fecal Faecalibacterium abundance was greater (P < 0.05) in dogs fed the low B. coagulans dose than those fed the high dose or controls. There were no interaction effects observed due to B. coagulans supplementation throughout the diet transition, but the abrupt transition to canned food reduced (P < 0.0001) fecal DM content and increased (P < 0.0001) fecal scores (looser stools) and pH. The diet transition also increased (P < 0.01) fecal Clostridium hiranonis, Collinsella, Fusobacterium, and Ruminococcus gnavus abundances and decreased (P < 0.01) fecal Bifidobacterium, Blautia, Faecalibacterium, Prevotella copri, Streptococcus, and Turicibacter abundances. Abundances of E. coli, Faecalibacterium, and Prevotella copri were modulated (P < 0.05) by B. coagulans supplementation alone. Our results demonstrate that although B. coagulans did not appear to attenuate shifts in fecal consistency and microbiota populations during an abrupt dietary change, this species may aid in maintaining stool quality and does not negatively impact nutrient digestibility or canine health.

PSIX-10 Effects of Bacillus subtilis ATCC PTA-122264 on macronutrient digestibility and fecal characteristics, metabolites, and microbiota of healthy adult dogs subjected to an abrupt diet change

Evaluation of Probiotic and Antimicrobial Potential of Canine Derived–<em>Lactobacilli</em>

PSIX-16 Effects of Bacillus coagulans GBI-30, 6086 on nutrient digestibility, fecal characteristics and metabolites, immunity, and microbiota of healthy adult dogs subjected to an abrupt diet change

Effects of Bacillus subtilis C-3102 addition on nutrient digestibility, faecal characteristics, blood chemistry and faecal Lactobacilli spp., Enterococci spp., and Escherichia coli in healthy dogs

Effects of Supplementation of Live and Heat-treated Bifidobacterium animalis subspecies lactis CECT 8145 on Glycemic and Insulinemic Response, Fecal Microbiota, Systemic Biomarkers of Inflammation, and White Blood Cell Gene Expression of Adult Dogs.

PSVI-23 Evaluation of graded levels of Bacillus coagulans (GBI-30, 6086) on apparent nutrient digestibility, stool quality, and intestinal health indicators in healthy adult dogs

Impact of Pediococcus acidilactici GLP06 supplementation on gut microbes and metabolites in adult beagles: a comparative analysis

Effects of probiotic Lactobacillus acidophilus strain DSM13241 in healthy adult dogs

Effects of dietary fiber and biotic supplementation on apparent total tract macronutrient digestibility and the fecal characteristics, metabolites, and microbiota of healthy adult dogs

Effects of Increasing Levels of Purified Beta-1,3/1,6-Glucans on the Fecal Microbiome, Digestibility, and Immunity Variables of Healthy Adult Dogs

Effect of Yeast Saccharomyces cerevisiae as a Probiotic on Diet Digestibility, Fermentative Metabolites, and Composition and Functional Potential of the Fecal Microbiota of Dogs Submitted to an Abrupt Dietary Change

The Effect of Probiotics Supplementation on the Gut Microbiome of Healthy Dogs Assessed Using Metagenomic Sequencing: A Randomized Control Trial

The Canine Gut Health: The Impact of a New Feed Supplement on Microbiota Composition

Supplementation of Yeast Cell Wall Fraction Tends to Improve Intestinal Health in Adult Dogs Undergoing an Abrupt Diet Transition

High-Fat Diets Led to OTU-Level Shifts in Fecal Samples of Healthy Adult Dogs

Modulation of broilers' caecal microflora and metabolites in response to a potential probiotic Bacillus amyloliquefaciens.

PSVIII-22 A Probiotic Blend Improves Fecal Quality and Enhances Gut Immunity in Dogs with Chronic Diarrhea

Effects of a probiotic Lactobacillus acidophilus strain on feed tolerance in dogs with non-specific dietary sensitivity

Effects of Synbiotics on the Fecal Microbiome and Metabolomic Profiles of Healthy Research Dogs Administered Antibiotics: A Randomized, Controlled Trial

Developmental stages in microbiota, bile acids, and clostridial species in healthy puppies

Oral Administration of Compound Probiotics Improved Canine Feed Intake, Weight Gain, Immunity and Intestinal Microbiota